Description

GLP-1 S

GLP-1 S is a long-acting analogue of the naturally occurring glucagon-like peptide-1 (GLP-1).

It enhances glucose-dependent insulin secretion, slows gastric emptying, and suppresses appetite, making it a leading compound for body-weight reduction and metabolic balance.
Beyond weight loss, it improves glycemic control, lipid metabolism, and cardiovascular markers, making it a cornerstone peptide in metabolic-optimization research.

RESEARCH

GLP-1 S is a synthetic peptide analog formulated exclusively for in vitro research involving analog stability and structural modeling. It is intended solely for laboratory studies focused on analog stability and structural modeling. It has been studied in non-clinical environments for its potential for resisting enzymatic breakdown and enhancing receptor interaction modeling in controlled research setting.

CHEMICAL INFORMATION

• Molecular Weight: 4113.58 Da
• CAS Number: 1997361-85-9

RESEARCH APPLICATIONS

• Structural investigation of peptide analog stability
• Modeling of receptor-ligand binding interactions in assay conditions
• Conjugation strategy comparisons in synthetic research
• Environmental degradation and preservation analysis under lab simulation
• Weight-management and obesity-reduction protocols
• Metabolic-syndrome and insulin-resistance studies
• Appetite-control and satiety research

STORAGE AND HANDLING

• Store lyophilized powder at -20°C
• Once reconstituted, store at 2–8°C and use promptly
• Use aseptic handling protocols to preserve sterility

PRODUCT SPECIFICATION

• Purity: ≥99% (HPLC Verified)
• Appearance: Lyophilized white powder
• Solubility: Soluble in bacteriostatic water

COMPLIANCE NOTICE

GLP-1 S is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA and is not to be used for therapeutic, diagnostic, or clinical purposes. Any misuse of this product may violate applicable laws and regulations. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.

BENEFITS BEING RESEARCHED

• Appetite and caloric intake through central satiety signaling
• Insulin sensitivity and stabilizes post-meal glucose levels
• Gradual and sustained fat loss without muscle depletion
• Lipid and cardiovascular profiles (↓ LDL, ↑ HDL)
• Pancreatic beta-cell preservation and glycemic resilience
• Metabolic flexibility and energy efficiency

MECHANISM OF ACTION (Simplified)

• GLP-1 receptors in the pancreas and brain → increases insulin secretion only when glucose is elevated
• Gastric emptying → prolonged satiety and reduced food intake
• Gucagon release → decreased hepatic glucose output
• Hypothalamic appetite control → reduced cravings and improved meal regulation

FORM / NOTES

• Lyophilized vials for reconstitution
• Standard dual incretin dosing for research use

LEGAL DISCLAIMER

This product is sold strictly for laboratory research use only.

By purchasing this product, the buyer represents and warrants that:

• The material will be used solely for in-vitro research purposes
• The buyer is qualified to handle laboratory reagents
• The product will not be used for human or animal consumption, injection, or application

Revyon Technologies assumes no liability for misuse or improper handling.

IMPORTANT NOTICE

Any use outside of stated research purposes is strictly prohibited.